HealthTech startup ecosystem
European healthtech startups are transforming care delivery, diagnostics, and drug discovery. Strong public health systems create natural testing grounds, while regulatory clarity through CE marking and the MDR framework gives European companies a path to scale. We track 207 organisations in this sector across 6+ countries.
Showing 161–180 of 207 HealthTech
Countries in this sector
Sectors alongside this one
HealthTech results
-
Przemysław Gacek
Founder of Grupa Pracuj and investor associated with Market One Capital (MOC), Przemysław focuses on marketplace models and network-effect businesses. He invests both personally and through fund activity, bringing strategic support in category creation, scaling, and international expansion. Notable portfolio references include Tier Mobility, Packhelp, and DocPlanner.
-
Qida
Qida (Grupo Qida) is a Spanish home care platform for elderly people, offering flexible caregiver services from a few hours a week to permanent live-in 24/7 care, plus weekend respite care covering hygiene, medication, meals, and companionship. Each family is paired with an experienced caregiver, a personal case manager, and a healthcare team, and the service is delivered with 365-day availability. Qida operates from offices in Sabadell (Barcelona), Madrid, Bilbao, and Pamplona, serving the regions of Catalonia, Madrid, the Basque Country, and Navarra.
-
Rafał Brzoska
Founder of InPost and one of Poland’s highest-profile entrepreneurs, Rafał is active as an impact-oriented investor through personal and foundation initiatives. His flagship company reached a landmark Amsterdam IPO, and his broader investment activity spans logistics-adjacent consumer sectors, food, and medical innovation. Notable references include activity around Bakalland and support for oncology and advanced medical equipment initiatives.
-
Revo Capital
Revo Capital is Turkey's largest technology-focused venture capital firm, founded in 2013 by Cenk Bayrakdar and Berkin Toktaş, having raised over $250M across three funds. Fund II closed at a landmark €90M in 2021 — oversubscribed with backing from IFC, EBRD, EIF, DEG, and the Turkish Development and Investment Bank — and Fund III reached an $86M first close in 2024 targeting over $100M. The firm has invested in 48 startups across Turkey, Eastern Europe, and the Baltics, achieving 18 exits and producing unicorns Getir and Builder.ai; portfolio companies have attracted $3.5B in follow-on capital between 2021 and 2025. Revo concentrates on early-stage B2B and B2C ventures in fintech, SaaS, cybersecurity, health tech, AI, and gaming.
-
Revolab
HealthTech company offering a CE-certified at-home finger-prick blood collection kit and digital platform; samples ship to partner labs and users get lab-grade results for 30+ tests within 24 hours.
-
Robeauté
Develops grain-of-rice-sized microrobots designed to navigate inside the human brain to deliver therapeutic molecules, implant electrodes or collect cellular data, aiming to make neurosurgery safer and more precise for conditions including glioblastoma.
-
Robert Ługowski
Founder of Polish Angels and managing partner at COBIN Angels, Robert is a veteran executive with experience at Xerox, HP, and Atos. He serves as a board member of the European Business Angels Network (EBAN) and specializes in business strategy and transaction structuring for early-stage deals. Notable involvements include CliniNote (AI-powered healthtech platform, co-founder), board roles with Photon Entertainment, Salesbook, and Vindicat, plus prior supervisory board service at Work Service S.A.
-
SABAH.HUB
SABAH.HUB is a private innovation center and accelerator founded in 2021 that supports startups at pre-seed and seed stages. It offers incubation, acceleration, and education tracks (SABAH.academy, SABAH.incubation, SABAH.lab) and has made 16 investments in its portfolio. It co-organizes the Baku Investment Day (Baku ID) conference in partnership with the World Economic Forum's Centre for the Fourth Industrial Revolution Network.
-
SagaNatura
SagaNatura is a Hafnarfjörður-based Icelandic biotech company producing premium natural ingredients from Iceland's pristine environment, including high-purity natural astaxanthin from microalgae and wild-grown organic Angelica Archangelica. The company traces its roots to SagaMedica (founded 2000) and KeyNatura (founded 2014), which merged to form the current entity. SagaNatura supplies nutraceutical ingredients to markets in North America and Asia-Pacific, and operates a consumer brand, KeyNatura, sold direct-to-consumer and through distributors worldwide. The company was tracking EUR 23 million in annual sales by 2025 and had been eyeing a potential IPO.
-
SANTEXPO 2026
Major French healthcare and hospital innovation expo with a large innovation village for digital health ventures. High-value event for founders targeting public-hospital procurement and clinical pilot partnerships.
-
ScandiBio Therapeutics
ScandiBio Therapeutics is a Stockholm-based pharmaceutical company developing AI-driven drugs that target mitochondrial dysfunction, a factor implicated in neurodegenerative disorders and metabolic syndromes. Its lead product has entered a randomized, double-blind, placebo-controlled Phase III clinical trial in Turkey for patients with mild, moderate, and severe Alzheimer's disease, and has also completed Phase II trials in fatty liver patients and Phase III trials in COVID-19 patients. The company was founded by scientists affiliated with KTH Royal Institute of Technology, Karolinska Institutet, Sahlgrenska University Hospital, and King's College London.
-
Semble
Clinical platform and EHR for outpatient and private healthcare providers, connecting scheduling, billing, telehealth and patient records in one system. Serves 1,700 customers including Nuffield Health; 10M+ UK patients have been seen by a clinician using it.
-
Sidekick Health
Sidekick Health is a Reykjavik- and Boston-based digital therapeutics company that builds disease-specific care programs delivered through a mobile app, combining behavior-change design, gamification, AI-driven personalization, and clinician oversight to help patients manage chronic conditions such as type 2 diabetes, obesity, cardiovascular risk, and certain cancers. Its programs are sold primarily to pharma companies, payers, and health systems that wrap them around drug therapy or chronic-care pathways, and the company has signed deals with several top-20 pharmaceutical manufacturers to run companion digital programs in multiple therapeutic areas. Founded by two Icelandic physicians, Sidekick is one of the most internationally visible examples of Icelandic health-tech, and together with Kerecis it shows that the country's life-sciences output extends from physical regenerative materials into software-as-medicine.
-
SNF Nostos 2026
Free week-long festival at the Stavros Niarchos Foundation Cultural Center, with the SNF Nostos Conference (June 22-26) bringing international speakers on health, education, climate and the future of society alongside concerts and interactive programming.
-
Sophia Bendz
A former Spotify executive turned prominent angel (and VC at Atomico), Sophia from Sweden has invested in Polish startups, particularly in fintech and healthtech. She was an early angel in Warsaw-based Doctorly and supports female-founded companies in Poland through programs like Lift Women. Associated startups: Doctorly, Village Network (and other Polish startups via Atomico Angel Programme).
-
Sophia Genetics
SOPHiA GENETICS is a Lausanne-based health-tech company founded in 2011 by Jurgi Camblong and Pierre Hutter as an EPFL spin-out. The company built a clinical AI platform — SOPHiA DDM — that enables hospital and laboratory networks to decode genomic data for oncology, rare disease, and pharmacogenomics applications. Its platform standardises and accelerates genomic analysis across a federated network of more than 780 healthcare institutions in 70 countries, turning each new clinical dataset into a contribution to a collectively smarter system. SOPHiA GENETICS listed on Nasdaq in July 2021, raising $228M, and is backed by Salesforce Ventures and Generation Investment Management. The company represents the EPFL ecosystem's capacity to produce globally significant clinical technology at scale.
-
Stanislas Niox-Chateau
Co-founder and CEO of Doctolib, the e-health booking and software platform he started in 2013. He scaled it into one of Europe's most valuable health-tech companies, serving hundreds of thousands of practitioners.
-
StethoMe
Connected smart stethoscope and AI platform that records and analyses lung and heart sounds for home-based respiratory diagnostics, paediatrics, and remote triage. Combines a CE-marked medical device with cloud-based AI that flags abnormal sounds for physicians. Backed by Movens Capital.
-
Sundose
Sundose was founded in 2017 by Michał Gołkiewicz and Tomasz Styk and launched commercially in Poland in 2018. The company runs a direct-to-consumer subscription model, personalising daily supplement sachets from dozens of ingredients based on a health questionnaire and optional blood-test data, and has expanded to the UK, Germany, and Italy. It raised a $6M Series A in 2021 led by DX Ventures and Atmos Ventures, with participation from Delivery Hero Ventures.
-
Sweden Innovation X
Organizer of digital health matchmaking events for Swedish innovation networks, bridging healthtech startups with hospitals, research institutions, and public sector buyers. Sweden Innovation X facilitates structured meetings and demo days, helping medtech and digital health founders validate solutions and secure pilot partnerships within Sweden's healthcare system.
